Quo vadis ureagenesis disorders? A journey from 90 years ago into the future
Journal of Inherited Metabolic Disease · 2024
DOI: 10.1002/jimd.12763 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, 2024. Verfasst von Johannes Häberle und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Metabolism and Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Urea Cycle Disorders, Inborn, Hyperammonemia, Urea. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, University Research Priority Program ITINERARE, Citrin Foundation.
Abstract (Originalsprache)
The pathway of ammonia disposal in the mammalian organism has been described in 1932 as a metabolic cycle present in the liver in different compartments. In 1958, the first human disorder affecting this pathway was described as a genetic condition leading to cognitive impairment and constant abnormalities of amino acid metabolism. Since then, defects in all enzymes and transporters of the urea cycle have been described, referring to them as primary urea cycle disorders causing primary hyperammonemia. In addition, there is a still increasing list of conditions that impact on the function of the urea cycle by various mechanisms, hereby leading to secondary hyperammonemia. Despite great advances in understanding the molecular background and the biochemical specificities of both primary and secondary hyperammonemias, there remain many open questions: we do not fully understand the pathophysiology in many of the conditions; we do not always understand the highly variable clinical course of affected patients; we clearly appreciate the need for novel and improved diagnostic and therapeutic approaches. This study does look back to the beginning of the urea cycle (hi)story, briefly describes the journey through past decades, hereby illustrating advancements and knowledge gaps, and gives examples for the extremely broad perspective imminent to some of the defects of ureagenesis and allied conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Metabolism and Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Division of Metabolic Diseases and Hepatology, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
ORCID-Profile: Johannes Häberle
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- University Research Priority Program ITINERARE
- Citrin Foundation
- Italian Ministry of Health with "Current Research" funds
Zitieren
APA
Häberle, J., Siri, B., & Dionisi-Vici, C. (2024). Quo vadis ureagenesis disorders? A journey from 90 years ago into the future. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12763
Vancouver
Häberle J, Siri B, Dionisi-Vici C. Quo vadis ureagenesis disorders? A journey from 90 years ago into the future. Journal of Inherited Metabolic Disease. 2024. doi:10.1002/jimd.12763
BibTeX
@article{Hberle2024,
author = {Häberle, Johannes and Siri, Barbara and Dionisi-Vici, Carlo},
title = {Quo vadis ureagenesis disorders? A journey from 90 years ago into the future},
journal = {Journal of Inherited Metabolic Disease},
year = {2024},
doi = {10.1002/jimd.12763}
}
EUVIMED